Bioluminescent reporter influenza A viruses to track viral infections
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.02150-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Ramya S Barre und 12 weiteren Autor:innen. Beteiligte Einrichtung: Texas Biomedical Research Institute, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Influenza A Virus, H1N1 Subtype, Orthomyxoviridae Infections, Influenza A virus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, American Lung Association.
Abstract (Originalsprache)
Influenza A viruses (IAVs) infect a wide range of mammalian and bird species and are responsible for seasonal outbreaks and occasional pandemics of great consequences in humans. Studying IAVs requires methods to detect the presence of the virus in infected cells or animal models. Recombinant IAV-expressing fluorescent proteins has allowed monitoring of viral infection in cultured cells and ex vivo in the organs of infected animals. However, fluorescent-expressing IAVs are often attenuated and are not suited for the imaging of infected animals using in vivo imaging systems (IVISs). To overcome this limitation, we generated a recombinant pandemic influenza A/California/04/2009 H1N1 (pH1N1)-expressing nanoluciferase (Nluc) from the non-structural viral segment, hereafter referred to as pH1N1-Nluc. The pH1N1-Nluc replicates efficiently in vitro , with growth kinetics and plaque morphology comparable to wild-type pH1N1 (pH1N1-WT). We used this pH1N1-Nluc to demonstrate its ability to effectively identify neutralizing monoclonal antibodies and antivirals, with neutralization and inhibition results comparable to pH1N1-WT. In mice, pH1N1-Nluc was able to induce similar body weight loss and mortality, and viral titers comparable to pH1N1-WT, results that were also recapitulated in a ferret model of IAV infection. Using IVIS, pH1N1-Nluc enabled non-invasive, real-time tracking of viral infection in vivo and ex vivo following infection of mice with viral titers in tissues comparable to pH1N1-WT. The flexibility of this approach was further demonstrated by the generation of a Nluc-expressing recombinant A/Puerto Rico/8/1934 H1N1 (PR8-Nluc). Altogether, our results demonstrate that Nluc-expressing recombinant IAVs represent a valuable tool for in vitro and in vivo studies, including the identification of antivirals and/or neutralizing antibodies, and to assess the protective efficacy of vaccines. IMPORTANCE Influenza A viruses (IAVs) pose a threat to human and animal health. Mechanisms that control IAV replication and pathogenesis are incompletely understood due to the lack of experimental approaches to visualize and quantify viral dynamics in real time. The use of replication-competent fluorescent-expressing IAV in vivo has been challenging because such viruses typically have reduced replication fitness and are not suited for imaging of entire animals. Herein, we developed replication-competent recombinant IAV-expressing nanoluciferase (Nluc) that can be used to visualize viral infection in living animals. Infection with Nluc-expressing IAV could be monitored in real time using in vivo imaging systems. Importantly, the Nluc reporter overcomes several shortcomings of fluorescent proteins and provides a new and sensitive tool to interrogate viral dynamics and immune responses in vitro and in vivo . This technology can be applied to advance studies and accelerate the development of new prophylactics and therapeutics against IAV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Texas Biomedical Research Institute, San Antonio, Texas, USA.
- Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA.
- Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Ramya S Barre, Ahmed Mostafa, Adolfo García-Sastre, James J Kobie, Aitor Nogales, Luis Martinez-Sobrido
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- American Lung Association
- Texas Biomedical Forum
- Texas Biomedical Research Institute
Zitieren
APA
Barre, R. S., Mostafa, A., Chiem, K., Pearl, R. L., Platt, R. N., Cupic, A., Anderson, T. J. C., Knaus, U. G., Albrecht, R. A., García-Sastre, A., Kobie, J. J., Nogales, A., & Martinez-Sobrido, L. (2025). Bioluminescent reporter influenza A viruses to track viral infections. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02150-25
Vancouver
Barre RS, Mostafa A, Chiem K, Pearl RL, Platt RN, Cupic A, et al. Bioluminescent reporter influenza A viruses to track viral infections. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02150-25
BibTeX
@article{Barre2025,
author = {Barre, Ramya S and Mostafa, Ahmed and Chiem, Kevin and Pearl, Rebecca L and Platt, Roy N and Cupic, Anastasija and Anderson, Timothy J C and Knaus, Ulla G and Albrecht, Randy A and García-Sastre, Adolfo and Kobie, James J and Nogales, Aitor and Martinez-Sobrido, Luis},
title = {Bioluminescent reporter influenza A viruses to track viral infections},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.02150-25}
}
EUVIMED